CN103445141B - One protects liver lotus nut starch - Google Patents
One protects liver lotus nut starch Download PDFInfo
- Publication number
- CN103445141B CN103445141B CN201310318693.4A CN201310318693A CN103445141B CN 103445141 B CN103445141 B CN 103445141B CN 201310318693 A CN201310318693 A CN 201310318693A CN 103445141 B CN103445141 B CN 103445141B
- Authority
- CN
- China
- Prior art keywords
- lotus nut
- nut starch
- liver
- chinese
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 240000002853 Nelumbo nucifera Species 0.000 title claims abstract description 22
- 235000006508 Nelumbo nucifera Nutrition 0.000 title claims abstract description 22
- 235000006510 Nelumbo pentapetala Nutrition 0.000 title claims abstract description 22
- 210000004185 liver Anatomy 0.000 title claims abstract description 21
- 229920002472 Starch Polymers 0.000 title claims abstract description 20
- 235000019698 starch Nutrition 0.000 title claims abstract description 20
- 239000008107 starch Substances 0.000 title claims abstract description 20
- 239000000843 powder Substances 0.000 claims abstract description 12
- 235000000832 Ayote Nutrition 0.000 claims abstract description 9
- 235000008440 Crataegus cuneata Nutrition 0.000 claims abstract description 9
- 244000160089 Crataegus cuneata Species 0.000 claims abstract description 9
- 235000014283 Crataegus pinnatifida var major Nutrition 0.000 claims abstract description 9
- 240000004244 Cucurbita moschata Species 0.000 claims abstract description 9
- 235000009854 Cucurbita moschata Nutrition 0.000 claims abstract description 9
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims abstract description 9
- 241000234435 Lilium Species 0.000 claims abstract description 9
- 240000006688 Telosma cordata Species 0.000 claims abstract description 9
- 235000017352 Telosma cordata Nutrition 0.000 claims abstract description 9
- 240000004922 Vigna radiata Species 0.000 claims abstract description 9
- 235000010721 Vigna radiata var radiata Nutrition 0.000 claims abstract description 9
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 claims abstract description 9
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 9
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 9
- 235000008397 ginger Nutrition 0.000 claims abstract description 9
- 235000015136 pumpkin Nutrition 0.000 claims abstract description 9
- 241001375196 Brandisia Species 0.000 claims abstract description 7
- 240000000249 Morus alba Species 0.000 claims abstract description 7
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 240000006432 Carica papaya Species 0.000 claims abstract description 6
- 235000009467 Carica papaya Nutrition 0.000 claims abstract description 6
- 240000002234 Allium sativum Species 0.000 claims abstract description 4
- 235000004611 garlic Nutrition 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 239000002002 slurry Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 17
- 210000004369 blood Anatomy 0.000 abstract description 3
- 239000008280 blood Substances 0.000 abstract description 3
- 230000036541 health Effects 0.000 abstract description 3
- 235000006264 Asimina triloba Nutrition 0.000 abstract description 2
- 230000003908 liver function Effects 0.000 abstract description 2
- 230000007774 longterm Effects 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 210000001835 viscera Anatomy 0.000 abstract description 2
- 241000222336 Ganoderma Species 0.000 description 13
- 206010028980 Neoplasm Diseases 0.000 description 9
- 201000011510 cancer Diseases 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 206010020751 Hypersensitivity Diseases 0.000 description 4
- 208000026935 allergic disease Diseases 0.000 description 4
- 230000007815 allergy Effects 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 230000002292 Radical scavenging effect Effects 0.000 description 3
- 206010006451 bronchitis Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 208000007514 Herpes zoster Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 230000036996 cardiovascular health Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 229940099472 immunoglobulin a Drugs 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229940126532 prescription medicine Drugs 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- IHZXTIBMKNSJCJ-UHFFFAOYSA-N 3-{[(4-{[4-(dimethylamino)phenyl](4-{ethyl[(3-sulfophenyl)methyl]amino}phenyl)methylidene}cyclohexa-2,5-dien-1-ylidene)(ethyl)azaniumyl]methyl}benzene-1-sulfonate Chemical compound C=1C=C(C(=C2C=CC(C=C2)=[N+](C)C)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S(O)(=O)=O)=C1 IHZXTIBMKNSJCJ-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 206010001513 AIDS related complex Diseases 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- RDMQPKIDHAFXKA-JNORPAGFSA-N Ganoderic Acid Am1 Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC(=O)C1=C2C(=O)C[C@]2(C)[C@@H]([C@@H](CC(=O)CC(C)C(O)=O)C)CC(=O)[C@]21C RDMQPKIDHAFXKA-JNORPAGFSA-N 0.000 description 1
- 229930182735 Ganoderic acid Natural products 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 241000175212 Herpesvirales Species 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102100037850 Interferon gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 208000029578 Muscle disease Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 206010036376 Postherpetic Neuralgia Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 206010044074 Torticollis Diseases 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- -1 beta-D glucan saccharide Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 201000010918 connective tissue cancer Diseases 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 230000002079 cooperative effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 230000006680 metabolic alteration Effects 0.000 description 1
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 230000037322 slow-wave sleep Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses one and protect liver lotus nut starch, it is made up of the raw material of following weight parts: Ganodenna Lucidum P.E 50-60, lotus nut starch 20-30, papaya powder 3-4, Chinese violet 1-2, ginger 1-3, garlic 1-2, lily 1-2, pumpkin flower 2-3, mung bean 3-4, oat 3-5, Chinese hawthorn seed 2-4, Hance Brandisia Herb 1-2, moutan bark 1-2, FI puerariae 2-3, Feng Huacao 1-2, red date 3-4, mulberry leaf 1-2.The liver lotus nut starch that protects of the present invention has very high health value, wherein red date effect of having five viscera settling to enrich blood, Chinese hawthorn seed has the effect of flat liver step-down, ginger, pawpaw, Chinese violet, lotus seeds, lily, pumpkin flower, mung bean etc. all have well protect liver function effect, powder of the present invention has no side effect, long-term edible can promote healthy.
Description
Technical field
The present invention relates generally to a kind of spore tablet, particularly relates to one and protects liver lotus nut starch.
Background technology
Ganodenna Lucidum P.E has following effect: active anticancer
The cancer research (such as: rat connective tissue cancer model) of animal has the tumor regression ratio of 50% after being presented at and utilizing Ganodenna Lucidum P.E to treat.Ganodenna Lucidum P.E is used for the treatment of cancer patient by the part surgeon of Japan, and in numerous case, notice its antitumor and immunostimulation significantly.The polysaccharide be separated from the medicinal mushroom of glossy ganoderma and other has obtained patent in Japan and be used as immunomodulator in treatment of cancer.It is mixed and demonstrate minimizing side effect with chemistry or radiotherapy, promotes the ability of result for the treatment of, and is used to promotion rehabilitation.
The research display Ganodenna Lucidum P.E of China strengthens the anti-tumor capacity of macrophage and T-cell.Ganodenna Lucidum P.E is known also has other immunoregulation effect and anti-oxidant properties.Zooscopy shows the saccharide portion of glossy ganoderma equally can the Apoptosis (programmed death of cancer cell) of inducing leukemia cell Cell Differentiation appears in the leukaemia when utilizing GL-B to treat induction of 40%-45%, proves its obvious treatment of cancer potentiality.These effects are main because the antitumor cell factor (signal agency) secretion that GL-B induction produces is risen, i.e. TNF-alpha and IFN-gamma, and these two kinds of cell factors are show cooperative effect at suppression leukemic cell growth.In a correlation test, the D-glucan saccharide portion of glossy ganoderma demonstrates when studying rat malignancy and produces theatrical tumor regression.With it many animals used as test, there is the decline completely of tumour by selecting colony after 5 weeks at injection beta-D glucan saccharide portion.Y. the Experimental report that carries out such as Song infected animal tumor suppression ratio of 90% and the tumor regression of 75% with it.
Improve immune system: (bronchitis, asthma, nasal allergy disease, herpetic disease and HIV)
Numerous constituents of Ganodenna Lucidum P.E immunity-regulating system, wherein part is considered to have obvious antitumor properties.Once comprise in the experiment of 2000 cases in China, after utilizing concentrated Garnoderma product treatment senile chronic bronchitis, demonstrate good reaction.This research shows the Success Ratio more than 60%.After the treatment of several months, there is obvious rising in the immunoglobulin A level in phlegm.Immunoglobulin A is the main immunoglobulin found in respiratory tract.Nasal allergy disease, in systemic lupus and rheumatoid arthritis, it generally there will be deficiency.Ganodenna Lucidum P.E replenishers once showed and improved asthma and nasal allergy symptom.Two kinds of important component of Ganodenna Lucidum P.E, oleic acid and the display of ring eight sulphur can suppress the release of histamine, this may be the reason for being what of value to asthma, a kind of special proteoglycan being called as Glhw-02 in Ganodenna Lucidum P.E, demonstrates the ntiviral characteristic having effective antagonism 1 type and 2 type pure viruses in laboratory conditions simultaneously.Once small-scale human experimentation display Ganodenna Lucidum P.E " dramatically " decreases the pain of two postherpetic neuralgia patients and having an intense pain of another two herpes zoster infection (herpes zoster causes because of herpesviral) patient.
In laboratory conditions, in Ganodenna Lucidum P.E, multiple ganoderic acid and polysaccharide display can be used as active AntiHIV1 RT activity material, and show reduce the ability that virus replication reaches 50% under conservative dose, after other east medicinal herbs mixing, glossy ganoderma is used to now to AIDS related complex, the treatment of AIDS, and separately or+mixedly with other medicinal material treat chronic fatigue syndrome.
Cardiovascular health: (hypertension and minimizing platelet aggregation)
Twice controlled human experimentation display Ganodenna Lucidum P.E can reduce hypertension to extremely obvious degree (systolic pressure and cardiac enlargement pressure), even for those before for the unresponsive patient of known antihypertensive drugs.Zoopery display Ganodenna Lucidum P.E is reduced blood pressure by the central inhibitory action of right sympathetic activity, although this effect substantially can not make decreased heart rate or cause sedation effect.In laboratory environments, Ganodenna Lucidum P.E has slightly builds up effect to the less blood platelet of moderate, and this function in the future may be helpful to minimizing trouble risk of cardiovascular diseases.It shows equally can increase endurance, and blood flows into brain flow and improves the oxygenation of cell.Similarly, it contributes to energy synthesis of cellular level, and it may improve cardiovascular health and for promoting memory and intelligence in some culture, comprising to the Successful utilization in Alzheimer's disease patient research.
Liver protection effect (protecting liver characteristic)
Glossy ganoderma is used for treatment that is chronic and oxyhepatitis as prescription medicine in China.Multiple polysaccharide in glossy ganoderma has very strong anti-hepatotoxin characteristic, and it demonstrates the liver protection effect under chemical induction injury in laboratory environments, comprises the protective effect to high toxicity and lifetime killer carbon tetrachloride.
Support nervous system
Glossy ganoderma is recommended the insomnia being used for coming because of its " sleep promoting element " traditionally by China and Japan herb doctor.Long-Time Service can cause the obvious promotion to slow wave sleep.Much psychiatry and neurological problems is used for by as prescription medicine Chinese glossy ganoderma, comprising muscle disease, weak after anorexia and prolonged sickness.
Antiallergy/anti-inflammatory effect
In the seventies and the eighties, the anti-allergic effects of glossy ganoderma becomes the problem of the ongoing research of China and Japan.Research display Ganodenna Lucidum P.E obviously suppresses all four class allergy, comprises the positive role to asthma and contact dermatitis.In nineteen ninety, scientist in University of Texas's health sciences center of San Antonio finds that glossy ganoderma can be used for the treatment of Wry Neck effectively, shoulder stiffness, conjunctivitis (being lining in mocromembrane in eyes and eyelid to be inflamed), bronchitis, rheumatism and improve immune system ability when not having apparent side effect.
The anti-inflammatory part ability of glossy ganoderma may be because of its radical scavenging activity.Ganodenna Lucidum P.E obviously promotes the radical scavenging activity of blood, particularly resists hydroxy radical harmful significantly.The Hydroxyl radical-scavenging ability of glossy ganoderma is so powerful so that still continues in Ganodenna Lucidum P.E its scavenging action after by absorption and metabolic alterations.
Anti-ageing
The classical Sheng Nong's herbal classic of medicine in time immemorial of China is recorded glossy ganoderma and effectively can be strengthened life energy (gas), increases thinking ability and prevents forgetful.It can recover body and intelligence, delays senility and makes the mankind can extending life.
Summary of the invention
The object of the invention is just to provide one and protects liver lotus nut starch.
The present invention is achieved by the following technical solutions:
One protects liver lotus nut starch, and it is made up of the raw material of following weight parts:
Ganodenna Lucidum P.E 50-60, lotus nut starch 20-30, papaya powder 3-4, Chinese violet 1-2, ginger 1-3, garlic 1-2, lily 1-2, pumpkin flower 2-3, mung bean 3-4, oat 3-5, Chinese hawthorn seed 2-4, Hance Brandisia Herb 1-2, moutan bark 1-2, FI puerariae 2-3, Feng Huacao 1-2, red date 3-4, mulberry leaf 1-2.
Protect a preparation method for liver lotus nut starch, comprise the following steps:
(1) by above-mentioned Chinese violet, lily, pumpkin flower, Hance Brandisia Herb, moutan bark, FI puerariae, Feng Huacao, mulberry leaf mixing, extracting in water, filters, merging filtrate;
(2) above-mentioned oat is added 6-7 times of poach to seethe with excitement to water, add mung bean, ginger, Chinese hawthorn seed, red date, keep boiling 5-6 minute, defibrination after cooling;
(3) filtrate obtained and slurry are mixed, filter after stirring, concentrate, be dried to powder;
(4) powder after above-mentioned process is mixed with each raw material of residue, stir, described in obtaining, protect liver lotus nut starch.
Advantage of the present invention is:
The liver lotus nut starch that protects of the present invention has very high health value, wherein red date effect of having five viscera settling to enrich blood, Chinese hawthorn seed has the effect of flat liver step-down, ginger, pawpaw, Chinese violet, lotus seeds, lily, pumpkin flower, mung bean etc. all have well protect liver function effect, powder of the present invention has no side effect, long-term edible can promote healthy.
Detailed description of the invention
Embodiment 1
One protects liver lotus nut starch, and it is made up of the raw material of following weight parts (kilogram):
Ganodenna Lucidum P.E 60, lotus nut starch 30, papaya powder 3, Chinese violet 2, ginger 3, garlic 1, lily 1, pumpkin spend 3, mung bean 4, oat 3, Chinese hawthorn seed 2, Hance Brandisia Herb 2, moutan bark 1, FI puerariae 3, Feng Huacao 2, red date 4, mulberry leaf 1.
Protect a preparation method for liver lotus nut starch, comprise the following steps:
(1) by above-mentioned Chinese violet, lily, pumpkin flower, Hance Brandisia Herb, moutan bark, FI puerariae, Feng Huacao, mulberry leaf mixing, extracting in water, filters, merging filtrate;
(2) above-mentioned oat is added 6 times of poach to seethe with excitement to water, add mung bean, ginger, Chinese hawthorn seed, red date, keep boiling 5 minutes, defibrination after cooling;
(3) filtrate obtained and slurry are mixed, filter after stirring, concentrate, be dried to powder;
(4) powder after above-mentioned process is mixed with each raw material of residue, stir, described in obtaining, protect liver lotus nut starch.
Claims (2)
1. protect a liver lotus nut starch, it is characterized in that it is made up of the raw material of following weight parts:
Ganodenna Lucidum P.E 50-60, lotus nut starch 20-30, papaya powder 3-4, Chinese violet 1-2, ginger 1-3, garlic 1-2, lily 1-2, pumpkin flower 2-3, mung bean 3-4, oat 3-5, Chinese hawthorn seed 2-4, Hance Brandisia Herb 1-2, moutan bark 1-2, FI puerariae 2-3, Feng Huacao 1-2, red date 3-4, mulberry leaf 1-2.
2. protect a preparation method for liver lotus nut starch as claimed in claim 1, it is characterized in that comprising the following steps:
(1) by above-mentioned Chinese violet, lily, pumpkin flower, Hance Brandisia Herb, moutan bark, FI puerariae, Feng Huacao, mulberry leaf mixing, extracting in water, filters, merging filtrate;
(2) above-mentioned oat is added 6-7 times of poach to seethe with excitement to water, add mung bean, ginger, Chinese hawthorn seed, red date, keep boiling 5-6 minute, defibrination after cooling;
(3) filtrate obtained and slurry are mixed, filter after stirring, concentrate, be dried to powder;
(4) powder after above-mentioned process is mixed with each raw material of residue, stir, described in obtaining, protect liver lotus nut starch.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310318693.4A CN103445141B (en) | 2013-07-26 | 2013-07-26 | One protects liver lotus nut starch |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310318693.4A CN103445141B (en) | 2013-07-26 | 2013-07-26 | One protects liver lotus nut starch |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103445141A CN103445141A (en) | 2013-12-18 |
| CN103445141B true CN103445141B (en) | 2016-02-10 |
Family
ID=49728319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310318693.4A Active CN103445141B (en) | 2013-07-26 | 2013-07-26 | One protects liver lotus nut starch |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103445141B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105341843A (en) * | 2015-11-04 | 2016-02-24 | 姚建成 | Preparation method of lotus nut starch with fragrance of flowers |
| CN106262508A (en) * | 2016-08-15 | 2017-01-04 | 邹健 | A kind of hepatoprotective lung moistening ginkgo powder and preparation method thereof |
| CN106262148A (en) * | 2016-08-18 | 2017-01-04 | 杨帆 | A kind of heat-clearing and toxic substances removing powder of Radix Puerariae and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102742880A (en) * | 2012-07-19 | 2012-10-24 | 湖南粒粒珍湘莲有限公司 | Preparation method of instant semen nelumbinis powder |
-
2013
- 2013-07-26 CN CN201310318693.4A patent/CN103445141B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102742880A (en) * | 2012-07-19 | 2012-10-24 | 湖南粒粒珍湘莲有限公司 | Preparation method of instant semen nelumbinis powder |
Non-Patent Citations (1)
| Title |
|---|
| 挤压膨化对莲子粉糊化度及容积密度影响的研究;薛军 等;《食品科学》;20071231;第28卷(第5期);第50-52页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103445141A (en) | 2013-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102302737B (en) | Traditional Chinese medicine composition for treating gastric cancer | |
| CN103445141B (en) | One protects liver lotus nut starch | |
| CN103571704A (en) | Preparation method of agilawood health-care wine and agilawood wine thereof | |
| RU2550016C1 (en) | Method of correcting processes of peroxidation of biomembrane lipids under conditions of ultraviolet irradiation | |
| CN104983751A (en) | Immunity-boosting ganoderma lucidum health care product and preparing method thereof | |
| CN105878899A (en) | Eatable drug having function of assisting treatment of gastric mucosal lesion and preparation method thereof | |
| CN103251880B (en) | Pharmaceutical composition for treating tumor and preparation method thereof | |
| CN104606261B (en) | A kind of zeolite pharmaceutical composition and its production and use | |
| CN104055802A (en) | Medicine for reducing side effects of chemoradiotherapy for tumour | |
| CN103446335A (en) | Conidial powder tablet with lucid ganoderma extract | |
| WO2015018471A1 (en) | Pni (psychoneuroimmunium) lobbyist cell protection | |
| CN103446472A (en) | Anti-aging lucid ganoderma and fructus lycii powder | |
| CN108514634A (en) | Navel plaster | |
| CN110721231B (en) | Traditional Chinese medicine composition for treating depression and preparation method thereof | |
| CN1611249A (en) | Antisenescent longevity powder | |
| CN104940702B (en) | Press down application of the dizzy peaceful particle in preparation treatment children suddenly hot infantile convulsion, tic of limbs drug | |
| CN1099282A (en) | Compound lotus plumule liquid and its preparation | |
| Pathak et al. | REVIEW OF RASAYAN IN CANCER TREATMENT, A NEED OF THE MODERN ERA | |
| CN104840727B (en) | Chinese medicine composition with anti-cancer of the esophagus activity and its preparation method and application | |
| CN110812385A (en) | Xiangshen capsule with good therapeutic effect on cancer, especially lung cancer, and preparation method and application thereof | |
| CN118217370A (en) | Compound taxol broad-spectrum anticancer Chinese medicinal preparation and its preparation method | |
| CN102233019A (en) | Biailing | |
| CN104127613A (en) | Traditional Chinese medicine preparation and caring method for treating child Tourette syndrome | |
| TWI614033B (en) | Use of an extract of cordyceps thereto | |
| CN102327421A (en) | Blood-activating and vitality circulation-promoting Chinese medicinal preparation for treating esophageal cancer and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20200806 Address after: 213159 standard workshop of HUTANG science and Technology Industrial Park, HUTANG Town, Wujin District, Changzhou City, Jiangsu Province Patentee after: Changzhou Jinjian Biotechnology Co., Ltd Address before: 236000 Anhui Province, Fuyang city Yingquan District Wen town Patentee before: Yang Dejun |